VWWMG
VIR icon

Vermillion & White Wealth Management Group’s Vir Biotechnology VIR Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-143
Closed -$862 – 517
2025
Q4 		$862 Buy
+143
New +$851 ﹤0.01% 540

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vermillion & White Wealth Management Group's VIR Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Vir Biotechnology (VIR) in Q1 2026, closing a stake of 143 shares — an estimated $862 sold.

Vermillion & White Wealth Management Group first reported a position in VIR in Q4 2025 and held it in 1 quarter. The position peaked at $862 in Q4 2025. 252 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Vermillion & White Wealth Management Group reported no remaining Vir Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Vermillion & White Wealth Management Group sold 143 Vir Biotechnology shares in Q1 2026, an estimated $862.
  • Vermillion & White Wealth Management Group first reported a position in Vir Biotechnology in Q4 2025 and held it in 1 quarter.
  • Vermillion & White Wealth Management Group's Vir Biotechnology position peaked at $862 in Q4 2025.
  • 252 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.